News

Media contact:
Molly Bowen

Announcements
Media Appearances
Press Releases
By Year

Cutting off immigrants from public benefits means American children will pay the price

Post Date:

2018-09-28

Source:

The Baltimore Sun

Dr. Kathleen Page's OpEd in The Baltimore Sun discusses ripple effects that cuts in benefits to immigrants mean for American kids.

Perspectives: How can we improve mental health services for people living with HIV in the Asia-Pacific?

Post Date:

2018-09-19

Source:

amFAR

People living with HIV are known to have higher rates of mental health issues, which can worsen their quality of life and affect adherence to HIV treatment.

Doctor who tackled HIV and other infectious diseases in India honored

Post Date:

2018-09-11

Source:

India Abroad

India Abroad article highlights the dedication of the Raj and Kamla Gupta Professorship in Infectious Diseases.

Amita Gupta and Sujata Bhatia: Doing a World of Good

Post Date:

2018-08-29

Source:

American Institute of Chemical Engineers

Amita Gupta is interviewed by AIChE about the intersection of chemical engineering and medicine.

$17M is awarded to support HIV, disease ecology, mHealth projects

Post Date:

2018-08-16

Source:

Global Health Matters

Larry Chang's Multidisciplinary Research Training to Understand and Reduce HIV Incidence in Uganda is among the funded projects.

Enhanced immigration enforcement in US could worsen HIV epidemic

Post Date:

2018-07-21

Source:

Infectious Disease News (via Healio)

Kathleen Page: Immigrants living in fear of deportation often limit the use of services that they believe could expose them to authorities.

Infectious Diseases Can Be Tackled, Here are 3 Solutions

Post Date:

2018-05-09

Source:

The Hill

Bob Bollinger: Quick delivery of care to sick patients eases the human impact and lowers the cost of disease.

Isoniazid preventive therapy: do the risks outweigh the benefits in pregnant women with HIV?

Post Date:

2018-03-13

Source:

aidsmap

. . . Isoniazid preventive therapy (IPT) during and after pregnancy in women living with HIV on antiretroviral therapy (ART) in tuberculosis (TB) endemic areas in Africa, Asia and Haiti resulted in serious adverse events quite possibly attributable to isoniazid with no significant reduction in TB...

Adverse pregnancy outcomes with isoniazid preventive therapy in HIV

Post Date:

2018-03-09

Source:

Infectious Disease Advisor

. . . The safety of IPT in pregnant women with HIV is unknown, especially with regard to its combination with highly active antiretroviral therapy (ART). Amita Gupta, MD, deputy director of the Johns Hopkins University Center for Clinical Global Health Education at the Johns Hopkins...

No difference in safety for HIV+ pregnant women deferring TB Tx

Post Date:

2018-03-09

Source:

MedPage Today

First randomized clinical trail of IPT in pregnant and postpartum women may suggest need for WHO guideline change.

Preventive TB therapy during pregnancy causes excessive adverse events

Post Date:

2018-03-08

Source:

Healio Infectious Disease News

. . . “Identifying ways to prevent TB during pregnancy and the postpartum period is a really important way to address maternal and infant health for a globally important disease such as tuberculosis,” Amita Gupta, MD, MHS, associate professor of medicine and international health and deputy director...